PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1605775
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1605775
Angio Suites Market size was valued at USD 2,503.21 Million in 2023, expanding at a CAGR of 6.20% from 2024 to 2032.
An Angio Suite a short for Angiography Suite, is a highly specialized, sterile medical environment equipped with advanced imaging technology to perform minimally invasive diagnostic and therapeutic procedures on blood vessels and the heart. It's commonly used in hospitals for interventional radiology, cardiology, and vascular surgeries.
Angio Suites Market- Market Dynamics
Rising tech advancement in imaging & interventional tools and growth in hybrid operating rooms is expected to propel market demand
Ongoing improvements in imaging technologies like 3D imaging and advanced X-ray systems and catheterization tools make Angio Suites more efficient and effective. These advancements enhance image quality, reduce procedure time, and increase the success rates of interventional procedures, which further drives market growth. With better awareness of interventional procedures' benefits, more patients are seeking these minimally invasive options. This demand is encouraging hospitals to install and upgrade Angio Suites to meet patient preferences and expand service offerings.
Angio Suites are increasingly integrated into hybrid operating rooms, which combine traditional surgical and interventional capabilities. These hybrid suites allow for complex, multi-disciplinary procedures, which are essential in treating conditions that may require both open surgery and catheter-based intervention. Aging populations are more susceptible to cardiovascular and vascular diseases, and this demographic trend is increasing demand for diagnostic and interventional vascular procedures. Angio Suites offer precise and safer treatment options for elderly patients, making them a preferred choice, thereby boosting market demand.
Angio Suites Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.20% over the forecast period (2024-2032)
Based on Type segmentation, the biplane angio suites segment was predicted to show maximum market share in the year 2023, as they are better multiple applications in angioplasty.
Based on Application segmentation, angioplasty segment was the leading Application segment in 2023, due to the high prevalence of cardiovascular diseases.
Based on End User segmentation, hospitals segment was the leading End User segment in 2023, mainly due to high demand for angio suites in hospital facilities for treatment of vascular disorders.
On the basis of region, North America was the leading revenue generator in 2023, due to the prevalence of coronary heart disease.
Global Angio Suites Market is segmented on the basis of Type, Application, End User, and Region.
The market is divided into two categories based on Type: single plane angio suites and biplane angio suites. The biplane angio suites segment dominates the market. Biplane angio suites offer more flexibility & convenience than other types.
The market is divided into four categories based on Application: angioplasty, therapeutic stenting, obstruction bypass, and others. The angioplasty segment dominates the market. High prevalence of cardiovascular, coronary heart diseases is mainly boosting segment growth.
The market is divided into three categories based on End User: hospitals, diagnostic centers, and ambulatory surgical centers. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. Angio Suites are widely used in hospitals for patient care as protective equipment which is accelerating market demand.
Angio Suites Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds the largest share of the Angio Suites market due to its robust healthcare infrastructure and technological advancements. Well-established hospitals and healthcare systems with significant investments in high-end technology, including Angio Suites. The U.S. has strong insurance coverage and reimbursement policies for interventional cardiology and radiology, driving adoption of these technologies. European countries have favorable government initiatives supporting healthcare innovation, including funding for modern medical facilities. In Asia Pacific, emerging economies like China and India are significantly increasing healthcare spending, focusing on modernizing hospitals and improving access to advanced medical technology.
The Angio Suites market is highly competitive, with several key players driving innovations and advancements in technology. The competition is primarily based on the development of new products, partnerships, mergers, and acquisitions to enhance market presence and offer integrated solutions in hospitals. Companies are investing in AI-powered imaging solutions, which improve real-time image processing, reduce radiation exposure, and enhance procedure accuracy. There is a growing demand for hybrid operating rooms, combining traditional surgery and interventional procedures in a single space, which has prompted major players to offer integrated solutions. This trend is particularly driven by increasing demand for multi-disciplinary procedures like cardiac and vascular surgeries. Philips and Siemens are especially active in emerging markets, offering flexible financing options and tailored solutions for smaller hospitals.
In September 2022, Leiden University Medical Center developed the Philips Spectral Angio CT suite and its use in clinical research, to bring in spectral CT imaging technology for treatment procedures.
In June 2022, Siemens Healthineers introduced angiography system called Artis icono ceiling for precise tumor embolization.